Literature DB >> 23414718

Opioids for chronic pain: new evidence, new strategies, safe prescribing.

Oscar A de Leon-Casasola1.   

Abstract

In the United States, the prevalence and burden of chronic pain is large and still growing. Older adults (aged ≥65 years) make up a large portion of the population with chronic pain, and their presentation, diagnosis, and treatment tends to be more complicated because of age-related physiological changes and comorbidities. Guidelines on treating patients with severe back pain recommend opioids as an option for those who do not find adequate pain relief from acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs). For older adult patients at higher risk for NSAID-related adverse effects, such as those who have gastrointestinal or cardiovascular disease, diabetes mellitus, or who are taking low-dose aspirin, opioids are recommended instead. Opioids may also be an appropriate option for patients with neuropathic pain who have not achieved adequate analgesia from maximum doses of first- and second-line antineuropathic agents. Still, opioids are not appropriate for all patients; rather, a differential diagnosis, consideration of other comorbidities, and the potential for opioid-related adverse effects and substance abuse are required to confirm the value of opioid treatment for each individual. For nonresponders to opioid therapy, opioid rotation should be considered before discontinuation is pursued.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23414718     DOI: 10.1016/j.amjmed.2012.11.011

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  27 in total

Review 1.  Pain pharmacology: focus on opioids.

Authors:  Diego Fornasari
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

2.  The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy.

Authors:  Alessandra Marengoni; Alessandro Nobili; Oscar Corli; Codjo Djignefa Djade; Diana Bertoni; Mauro Tettamanti; Luca Pasina; Salvatore Corrao; Francesco Salerno; Maura Marcucci; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2014-09-24       Impact factor: 3.397

3.  Randomized Controlled Trial of Telephone-delivered Cognitive Behavioral Therapy Versus Supportive Care for Chronic Back Pain.

Authors:  Thomas Rutledge; J Hampton Atkinson; Tatiana Chircop-Rollick; John D'Andrea; Steven Garfin; Shetal Patel; Donald B Penzien; Mark Wallace; Anne L Weickgenant; Mark Slater
Journal:  Clin J Pain       Date:  2018-04       Impact factor: 3.442

Review 4.  Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?

Authors:  Felicity C Veal; Gregory M Peterson
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

5.  Pain Severity in Relation to the Final Menstrual Period in a Prospective Multiethnic Observational Cohort: Results From the Study of Women's Health Across the Nation.

Authors:  Yvonne C Lee; Arun S Karlamangla; Zhi Yu; Chih-Chin Liu; Joel S Finkelstein; Gail A Greendale; Siobán D Harlow; Daniel H Solomon
Journal:  J Pain       Date:  2016-11-09       Impact factor: 5.820

6.  BETWEEN A ROCK AND A HARD PLACE: CAN PHYSICIANS PRESCRIBE OPIOIDS TO TREAT PAIN ADEQUATELY WHILE AVOIDING LEGAL SANCTION?

Authors:  Kelly K Dineen; James M DuBois
Journal:  Am J Law Med       Date:  2016

Review 7.  Chronic low back pain: pharmacological, interventional and surgical strategies.

Authors:  Bart Morlion
Journal:  Nat Rev Neurol       Date:  2013-07-02       Impact factor: 42.937

8.  Analgesic Effects of Danggui-Shaoyao-San on Various "Phenotypes" of Nociception and Inflammation in a Formalin Pain Model.

Authors:  Jun-Bin Yin; Ke-Cheng Zhou; Huang-Hui Wu; Wei Hu; Tan Ding; Ting Zhang; Li-Ying Wang; Jun-Ping Kou; Alan David Kaye; Wen Wang
Journal:  Mol Neurobiol       Date:  2015-12-12       Impact factor: 5.590

9.  Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy.

Authors:  William C Becker; David A Fiellin; Anne C Black; Carol T Kostovich; Robert D Kerns; Liana Fraenkel
Journal:  J Rehabil Res Dev       Date:  2016

10.  Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice.

Authors:  Ana M Moreno; Fernando Alemán; Glaucilene F Catroli; Matthew Hunt; Michael Hu; Amir Dailamy; Andrew Pla; Sarah A Woller; Nathan Palmer; Udit Parekh; Daniella McDonald; Amanda J Roberts; Vanessa Goodwill; Ian Dryden; Robert F Hevner; Lauriane Delay; Gilson Gonçalves Dos Santos; Tony L Yaksh; Prashant Mali
Journal:  Sci Transl Med       Date:  2021-03-10       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.